Strontium ranelate retards disc degradation and improves endplate and bone micro-architecture in ovariectomized rats with lumbar fusion induced – Adjacent segment disc degeneration
Objectives: Adjacent segment disc degeneration (ASDD) is one of the long-term sequelae of spinal fusion, which is more susceptible with osteoporosis. As an anti-osteoporosis drug, strontium ranelate (SR) has been reported to not only regulate bone metabolism but also cartilage matrix formation. Howe...
Main Authors: | Qi Sun, Fang Liu, Jiakang Fang, Qiangqiang Lian, Yunpeng Hu, Xinyu Nan, Fa-Ming Tian, Guochuan Zhang, Dianwen Qi, Liu Zhang, Jingwen Zhang, Yang Luo, Zuzhuo Zhang, Zhuang Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Bone Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187224000111 |
Similar Items
-
Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01) -
Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01) -
THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01) -
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01) -
Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)